Page last updated: 2024-10-24

regulation of blood volume by renal aldosterone

Definition

Target type: biologicalprocess

The process in which the hormone aldosterone decreases the rate of diuresis and natriuresis resulting in increased blood volume. [GOC:dph, GOC:tb, ISBN:0721643949]

The regulation of blood volume by renal aldosterone is a complex process that involves the coordinated action of several hormones and organs. The main players in this process are the kidneys, the adrenal glands, and the renin-angiotensin-aldosterone system (RAAS).

**Here's how the process works:**

1. **Decreased blood volume:** When blood volume decreases, the body senses this through a variety of mechanisms, including a decrease in blood pressure and an increase in blood osmolality. This triggers the release of renin from the kidneys.

2. **Renin release:** Renin is an enzyme that converts angiotensinogen, a protein produced by the liver, into angiotensin I.

3. **Angiotensin I conversion:** Angiotensin I is then converted to angiotensin II by angiotensin-converting enzyme (ACE), which is found in the lungs.

4. **Angiotensin II actions:** Angiotensin II has several important effects, including:
- **Vasoconstriction:** Angiotensin II causes blood vessels to constrict, which increases blood pressure.
- **Stimulation of aldosterone release:** Angiotensin II stimulates the adrenal glands to release aldosterone.

5. **Aldosterone release:** Aldosterone is a hormone that acts on the kidneys to increase sodium reabsorption and potassium excretion. This effect is mediated by aldosterone receptors in the distal tubules and collecting ducts of the nephrons.

6. **Increased sodium reabsorption:** By increasing sodium reabsorption, aldosterone indirectly increases water reabsorption. This is because water follows sodium passively.

7. **Increased blood volume:** The net effect of these actions is to increase blood volume and blood pressure.

**Feedback mechanisms:**

The RAAS is tightly regulated by a variety of feedback mechanisms. For example, when blood volume and pressure increase, the release of renin is suppressed. This helps to prevent excessive increases in blood volume and pressure.

**Other factors:**

Several other factors can also affect blood volume regulation, including:
- **Antidiuretic hormone (ADH):** ADH, also known as vasopressin, is released from the pituitary gland in response to dehydration. ADH increases water reabsorption in the kidneys.
- **Atrial natriuretic peptide (ANP):** ANP is a hormone released from the heart in response to increased blood volume. ANP promotes sodium excretion and reduces blood volume.

**Clinical implications:**

Dysregulation of the RAAS can lead to a number of health problems, including hypertension, heart failure, and kidney disease. Drugs that target the RAAS, such as ACE inhibitors and angiotensin II receptor blockers, are commonly used to treat these conditions.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Corticosteroid 11-beta-dehydrogenase isozyme 2An 11-beta-hydroxysteroid dehydrogenase type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P80365]Homo sapiens (human)
Cytochrome P450 11B2, mitochondrialA cytochrome P450 11B that is a translation product of the CYP11B2 gene in human. [PRO:DNx, UniProtKB:P19099]Homo sapiens (human)

Compounds (28)

CompoundDefinitionClassesRoles
fluconazolefluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
conazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug
environmental contaminant;
P450 inhibitor;
xenobiotic
ketoconazole1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.dichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
letrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
metyraponemetyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
aromatic ketoneantimetabolite;
diagnostic agent;
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
glycyrrhetinic acidcyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid
immunomodulator;
plant metabolite
glycyrrhizic acidglycyrrhizinic acid : A triterpenoid saponin that is the glucosiduronide derivative of 3beta-hydroxy-11-oxoolean-12-en-30-oic acid.enone;
glucosiduronic acid;
pentacyclic triterpenoid;
tricarboxylic acid;
triterpenoid saponin
EC 3.4.21.5 (thrombin) inhibitor;
plant metabolite
staurosporineindolocarbazole alkaloid;
organic heterooctacyclic compound
apoptosis inducer;
bacterial metabolite;
EC 2.7.11.13 (protein kinase C) inhibitor;
geroprotector
fadrozoleFadrozole: A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.imidazopyridine
1-benzylimidazole1-benzylimidazole: inhibits human thromboxane synthetase
11-hydroxyprogesterone, (11alpha)-isomer11alpha-hydroxyprogesterone : A 11alpha-hydroxy steroid that is pregn-4-ene-3,20-dione substituted by a hydroxy group at position 11.11alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid
acetylglycyrrhetinic acidacetylglycyrrhetinic acid: RN given refers to (3beta,20beta)-isomertriterpenoid
3-oxoglycyrrhetinic acidpentacyclic triterpenoid
abiraterone3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
pyridines
antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
ketoconazole(2R,4S)-ketoconazole : A cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine which dioxolane moiety has (2R,4S)-configuration.cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
posaconazolearomatic ether;
conazole antifungal drug;
N-arylpiperazine;
organofluorine compound;
oxolanes;
triazole antifungal drug;
triazoles
trypanocidal drug
1-(phenylmethyl)benzimidazolebenzimidazoles
carbenoxolone
etomidateetomidate : The ethyl ester of 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylic acid. It is an intravenous general anaesthetic with no analgesic activity.

Etomidate: Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
ethyl ester;
imidazoles
intravenous anaesthetic;
sedative
1-[(3-methylphenyl)methyl]benzimidazolebenzimidazoles
4-fluoro-N-(3-pyridinyl)benzamidecarbonyl compound;
organohalogen compound
4-(1H-imidazol-1-ylmethyl)benzonitrilebenzenes;
nitrile
3-(1-adamantyl)-6,7,8,9-tetrahydro-5h-(1,2,4)triazolo(4,3-a)azepine
bvt2733
mk-0916MK-0916: structure in first source
pf 915275
colletoic acidcolletoic acid: an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor from Colletotrichum gloeosporioides; structure in first source
osilodrostatOsilodrostat: an orally active aldosterone-synthase inhibitor
amg 221AMG 221: structure in first source